Introduction {#sec0005}
============

During recent decades, there has been a significant increase in the incidence of twin pregnancies. \[[@bib0005]\] This trend is accounted for both by the increase in maternal age in developed countries, and the rise in pregnancies achieved by assisted reproductive technologies. According to the American Society for Assisted Reproductive Technology (SART), approximately 8 percent of pregnancies conceived through assisted reproductive technology in 2016 were twin pregnancies \[[@bib0010]\]. Patients with multiple gestations possess higher risk for fetal genetic and chromosomal anomalies compared to singleton pregnancies, and dizygotic twin pregnancies have approximately twice the singleton risk of an affected fetus \[[@bib0015]\]. As a result, the genetic workup, which in most cases includes amniocentesis to obtain fetal cells for analysis, has an important role in the prenatal evaluation of these pregnancies. \[[@bib0020]\] While the risk of pregnancy loss after amniocentesis in singleton pregnancies is well established \[[@bib0025],[@bib0030]\], a paucity of data exists regarding the risk in twin pregnancies \[[@bib0035]\]. Studies have demonstrated different rates of pregnancy loss following amniocentesis in twin pregnancies, ranging from 0 to 9 percent \[[@bib0020],[@bib0035]--[@bib0045]\].

One of the factors that might influence amniocentesis complications rate is the sampling technique -- a single uterine entry technique with sampling of both gestational sacs following one puncture, versus a double uterine-entry technique and separate punctures of each sac. \[[@bib0035]\]

There is an insufficient body of data addressing the relationship between sampling technique and pregnancy outcome \[[@bib0050]\]. Thus, we aimed to investigate the potential impact of amniocentesis technique on related complications in a large cohort of twin pregnancies.

Materials and methods {#sec0010}
=====================

Study cohort {#sec0015}
------------

A retrospective cohort study of all women carrying twin gestation who underwent amniocentesis during pregnancy and delivered in a single university-affiliated tertiary hospital, between October 2002 and February 2016. The cohort was divided into two groups according to amniocentesis technique with regard to the number of trans-abdominal needle applications. Procedures in which a single trans-abdominal needle insertion was performed were compared to procedures using the double insertion technique. Amniocentesis related complication rates were investigated in both groups. Our local institutional review board (0165-16-RMC) approved the study. Informed consent was waived due to the retrospective design of the study and in accordance with good clinical practice.

Our hospital is a referral center for high-risk pregnancies. Thus, we were able to access a large cohort of women with twin pregnancies who were carefully followed during pregnancy and then delivered in the same institution. Some of these pregnancies underwent amniocentesis. The indications for amniocentesis during twin gestation are variable. Our study included only indications that are recommended and funded by the Ministry of Health, in accordance with Israeli guidelines: (1) amniocentesis for fetal karyotype when maternal age exceeds 35 years; (2) suspected anatomical anomalies demonstrated by ultrasound during primary or secondary anatomical survey; (3) Cytomegalovirus (CMV) seroconversion when diagnosed during pregnancy. Amniocentesis to trace virus presence in the amniotic fluid is recommended after 21 weeks of gestation and at least 6 weeks after suspected maternal exposure to virus; and(4) when recommended during genetic counseling generally because of abnormal results in the first or second trimester screening, or when there was hereditary disease in the family.

The following cases were excluded: 1) method of amniocentesis was not clear or puncture was made only in a single sac; 2) termination of pregnancy; 3) feticide of a single embryo; 4) fetal chromosomal anomalies; 5) monochorionic monoamniotic twins; and 6) missing data we were not able to attain.

The timing for amniocentesis depended on the indication for the procedure. Elective procedures indicated due to maternal age or pathological screening tests were held at 17 + 0--22 + 6 weeks of gestation. Subsequent procedures were initiated as a result of findings diagnosed later in pregnancy.

Procedure {#sec0020}
---------

All procedures were performed by well trained, experienced senior Ob-Gyn physicians specialized in ultrasound. For the investigated cohort, amniocentesis was performed by seven elected physicians and 84% of cases were performed by three of them. After elaborating on the risks associated with amniocentesis, informed consent was obtained from the patient. The procedure was performed under continuous ultrasound vision. Initially, the first selected amniotic sac was punctured and amniotic fluid aspirated. In most cases, after aspirating the required amount of fluid for genetic analysis, color was injected into the same sac, to mark the first-entered amniotic sac. The entrance to the second amniotic sac involved injecting a needle into the inter-twin membrane (single insertion) or directly into the uterus (double insertion). The procedure was completed when amniotic fluid from the second sac was obtained.

Data collection {#sec0025}
---------------

Data regarding the procedure, pregnancy, and birth were retrieved from our departmental comprehensive computerized perinatal database, and cross-tabulated using an individualized identification number per patient. Data from the ultrasound unit and the neonatal intensive care unit (NICU) were integrated into the delivery ward database.

The following baseline characteristics were recorded: maternal age, gravidity, parity, previous preterm labor, pregnancy achieved by assisted reproductive technology, twin amnionicity and chorionicity, fetal gender, gestational age at amniocentesis and placental location. Missing data was obtained through a careful manual chart review performed by the study personnel or by calling the patient\'s personal physician after receiving informed consent.

Primary outcome was defined as the ***composite complications outcome***, including any one of the following amniocentesis related complications occurring within 4 weeks post procedure: late abortion, chorioamnionitis, premature rupture of membranes, or hospitalization for observation in gynecologic ward due to procedure associated symptoms (i.e. fever above 38 ^º^C, premature contractions, abdominal pain and tenderness). Secondary outcomes were labor characteristics.

Outcomes were stratified for study groups according to amniocentesis technique: single vs. double insertion.

Statistical analysis {#sec0030}
--------------------

Pregnancy loss rates related to twin amniocentesis range from 0% and up to 9% in different studies \[[@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045]\], Using the Epi-info™, program for this pregnancy loss frequencies assuring 80% power with a limit of 0.05 for type I error; a sample size of 116 cases for each subgroup is needed. Since we performed a retrospective design for our study, and used all cases eligible according to the inclusion criteria, we defined a primary outcome composed of any procedure associated complications. Post-hoc power analysis calculated with the above-mentioned definitions, for a complication's frequency of 14%, a sample size of 64 cases is needed for each subgroup.

Data analysis was performed using the SPSS v21.0 package (Chicago, IL). Continuous variables were compared using the Student\'s *t*-test and Mann-Whitney U test. The chi-square and Fisher\'s exact tests were used for categorical variables. Differences were considered significant when the p-value was less than 0.05. Following the bivariate analysis, logistic regression analysis was utilized to adjust outcomes for potential confounders. Variables with clinical impacts or that differed significantly between the groups (p \< 0.05) in the bivariate analysis entered the regression model: maternal age, gravidity, parity, previous preterm labor, gestational age at amniocentesis and composite complications outcome.

Results {#sec0035}
=======

During the study period, 309 mothers with twin pregnancies underwent amniocentesis and delivery in our institution; 212 (68.6%) met the inclusion criteria. In 73 (34.4%) cases amniocentesis was performed by a single uterine entry, and in 139 (65.6%) cases amniocentesis was performed by double uterine entry. A total of 97 cases were excluded as presented in [Fig. 1](#fig0005){ref-type="fig"}.Fig. 1Study cohort selection.Fig. 1

Baseline characteristics of women in both groups are presented in [Table 1](#tbl0005){ref-type="table"}. No significant difference was found between the groups regarding demographic characteristics, prior preterm labor, and indication for procedure, or placental location. The majority of the women carried a bichorionic twin pregnancy and only 20 women carried a monochorionic diamniotic pregnancy. Of them, four underwent a single uterine entry and 16 underwent a double uterine entry. Thus, chorionicity did not differ between study groups (p = 0.149). The use of color as elaborated in the Methods section was performed in 190 (89.6%) of all cases; while a higher rate of its use was documented in the single insertion technique (95.6% vs. 86.3% in the double insertion technique, p = 0.03).Table 1Baseline characteristics for the study groups.Table 1VariableSingle insertion (N = 73)Double insertion (N = 139)p valueMaternal age (years)34.7 ± 4.834.9 ± 4.80.828Gravidity2.3 ± 1.42.8 ± 1.70.071Parity0.9 ± 0.91.2 ± 1.10.147**Previous preterm labor** \<37 weeks5/63 (7.9)11/112 (8.9)0.915 \<34 weeks1/63 (1.6)2/123 (1.6)0.984 Assisted reproductive technology41/63 (65.1)71/119 (59.7)0.555Chorionicity0.149 Bichorionic diamniotic58(93.5)102(86.4) Monichorionic diamniotic4(6.5)16**Indication for amniocentesis**0.914 Maternal age \>35 years36/71 (50.7)62/135 (45.9)-- Maternal request9/71 (12.7)20/135 (14.8)-- Anatomic anomalies16/71 (22.5)36/135 (26.7)-- CMV seroconversion2/71 (2.8)4/135 (3)-- Genetic counseling8/71 (11.3)12/135 (8.9)--**Male neonates** Fetus \#138/65 (58.5)67/118 (56.8)0.379 Fetus \#235/65 (58.3)48/116 (41.4)0.094 Gestational age at amniocentesis (weeks)19.6 ± 4.120.3 ± 4.680.296**Anterior placenta** Fetus \#143/71 (60.6)63/135 (46.6)0.363 Fetus \#229/68 (42.7)66/134 (49.3)0.477 Use of color in amniocentesis70/73 (95.9)120/139 (86.3)0.030[^2][^3]

Bivariate analysis of individual and composite complications outcomes is presented in [Table 2](#tbl0010){ref-type="table"}. Regarding primary outcome as defined in the Methods section, no significant difference was demonstrated between the groups. A composite complications outcome rate of 13.7% was found in the single insertion technique vs. 16.5% in the double insertion technique (p = 0.587). A specific analysis of the monochorionic twin subgroup demonstrated an overall frequency of the composite complications outcome of up to 40%. Moreover, the only one case of abortion ascribed to amniocentesis (0.5%) that was identified in the cohort and was found in the double entry group was a monochorionic twin gestation. The patient presented at 19 weeks of gestation, two weeks following the procedure, with no cardiac activity to both twins.Table 2Amniocentesis related complication rates.Table 2VariableSingle insertion (N = 73)Double insertion (N = 139)p value**Complications within 4 weeks after Amniocentesis** Late abortion0/65 (0)1/125 (0.8)0.470 Chorioamnionitis0/62 (0)1/118 (0.8)0.655 PPROM3/62 (4.8)6/122 (4.9)0.981 Hospitalization6/62 (9.7)16/118 (13.6)0.655**Composite complications outcome**[\*](#tblfn0005){ref-type="table-fn"}9/73 (13.7)24/139 (16.5)0.587[^4][^5][^6]

Following adjustment for potential confounders as elaborated in the Methods section, amniocentesis technique was not associated with composite complication outcome (OR = 1.085, 95% CI 0.4--2.9, p = 0.871).

Labor characteristics for the study groups are presented in [Table 3](#tbl0015){ref-type="table"}. No differences regarding pregnancy complications, induction of labor or mode of delivery were found between the groups. The mean gestational age at delivery was 35.1 weeks and birth weights were statistically similar in both study groups.Table 3Pregnancy and labor characteristics for the study groups.Table 3VariableSingle Insertion (N = 73)Double Insertion (N = 139)p valuep value**Pregnancy complications** Pre-eclampsia5/59 (8.5)12/118 (10.2)0.7180.718 Gestational DM7/61 (11.5)15/118 (12.7)0.5930.593 Suspected intrauterine growth restriction7/61 (11.5)17/116 (14.7)0.5570.557 Twin to twin transfusion syndrome0/61 (0)1/118 (0.8)0.4710.471  **Labor characteristics** Labor induction29/61 (47.5)63/118 (53.4)0.2980.298 Cesarean delivery51/67 (76.1)101/126 (80.2)0.3070.307 Gestational age at delivery (weeks)35.1 ± 3.035.1 ± 2.90.9730.973  **Birth weight (grams)** Fetus \#12169.2 ± 506.22324.3 ± 550.30.0710.071 Fetus \#22145.5 ± 553.52198.7 ± 502.60.5290.529[^7][^8]

Discussion {#sec0040}
==========

This study sought to evaluate the association between amniocentesis technique and pregnancy complications in twin pregnancies, comparing single uterine entry to conventional double uterine entry, and found the two methods comparable. Pregnancies complications directly relate to amniocentesis are known to occur within 4 weeks following the procedure \[[@bib0055], [@bib0060], [@bib0065]\]. Thus, we presented a primary outcome composite comprised of complications occurring up to 4 weeks following the procedure. The results showed that both techniques were similar in terms of pregnancy and complications outcomes.

A single uterine entry technique, as was described in several studies, requires good visualization of the amniotic membranes in order to advance the same needle into both gestational sacs \[[@bib0050],[@bib0070],[@bib0075]\]. This procedure was described as both swift and easy, and reduces discomfort to the patient \[[@bib0070]\].

It is commonly accepted that the risk for adverse outcome rises with increase in number of uterine entries during the procedure \[[@bib0035]\]. We hypothesized that single uterine entry technique might present a lower complications rate compared to the double uterine entry technique, and might resemble published complications rates in singleton pregnancies. However, single uterine entry technique is more complex than the singleton amniocentesis since it requires the passage through the inter-twin membrane, which exposes one of the gestational sacs to two different amniotic punctures (one at the entry and the second through the inter-twin membrane). Moreover, the single-entry technique raises the theoretical risk of inter-twin membrane rupture, evidence for this hypothesis is lacking.

To date, only one study has addressed the effect of number of uterine entries during amniocentesis of twin pregnancies on pregnancy outcomes \[[@bib0050]\]. In that study, the authors reviewed 100 cases of amniocentesis in twin pregnancies described total fetal loss before 24 weeks or PPROM \< 34 weeks at a rate of 1 (2.7%) (n = 37) for single entry vs. 3 (4.76%) (n = 63) for double entry, with no statistic significant differences (RR = 0.57). Our study of a larger cohort of 212 pregnancies, showed similar results. This sample size is correlated with the power calculations and presents a much larger cohort compared to previous studies. The lack of statistically significant differences between the two groups, despite our larger sample size and adequate power as elaborated in the statistical analysis section, may be attributed to the very low rate of fetal loss in our study (0.5%) which is consistent with some earlier studies \[[@bib0070], [@bib0075], [@bib0080], [@bib0085]\].

In general, our results compare favorably with the literature in terms of gestational age at delivery, complication rate and birth weight \[[@bib0035],[@bib0040]\]. However, to the best of our knowledge, our study includes one of the largest cohorts of twin pregnancies who underwent amniocentesis reported in the literature.

Another potential problem with single uterine entry technique, is that it may cause sampling errors or cross contaminations \[[@bib0020],[@bib0050]\]. In our series, there were no such complications. This might be attributed to our well experienced procedure operators, to the widely used color injection and to the thorough ultrasound evaluation conducted both prior to and during the procedure.

The strengths of our study are the relatively large sample size and the detailed prenatal information we were able to collect. Operator dependent complications bias was diminished by an elected group of well experienced operators. Limitations include the retrospective design, the lack of randomization for procedure technique and the small numbers of monochorionic twin gestation that constrained our ability to imply significant results over this subgroup.

In conclusion, we found similar pregnancy outcomes for twin pregnancies following amniocentesis by a single or double uterine entry technique. Both techniques are optional and medically acceptable. Choice should be left to the operator considering their skills and real-time ultrasound findings.
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[^2]: For all variables, categorical data are presented as n/N (%) and continuous variables are presented as average±2 SD.

[^3]: CMV, cytomegalovirus.

[^4]: For all variables, categorical data are presented as n/N (%).

[^5]: PPROM, preterm premature rupture of membranes.

[^6]: Composite includes any of the following within 4 weeks of amniocentesis: Late abortion, chorioamnionitis, pre-term premature rupture of membranes, or hospitalization.

[^7]: For all variables, categorical data are presented as n/N (%); continuous variables are presented as average± 2SD.

[^8]: DM, diabetes mellitus.
